Arizona State Retirement System’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.08M | Buy |
56,018
+943
| +2% | +$51.8K | 0.02% | 593 |
|
2025
Q1 | $3.89M | Sell |
55,075
-205
| -0.4% | -$14.5K | 0.02% | 489 |
|
2024
Q4 | $3.63M | Buy |
55,280
+880
| +2% | +$57.8K | 0.02% | 524 |
|
2024
Q3 | $3.82M | Buy |
54,400
+2,270
| +4% | +$160K | 0.02% | 518 |
|
2024
Q2 | $4.29M | Buy |
52,130
+320
| +0.6% | +$26.3K | 0.03% | 441 |
|
2024
Q1 | $4.53M | Buy |
51,810
+92
| +0.2% | +$8.04K | 0.03% | 438 |
|
2023
Q4 | $4.99M | Buy |
51,718
+510
| +1% | +$49.2K | 0.04% | 389 |
|
2023
Q3 | $4.53M | Buy |
51,208
+10
| +0% | +$885 | 0.04% | 383 |
|
2023
Q2 | $4.44M | Sell |
51,198
-2,833
| -5% | -$246K | 0.04% | 404 |
|
2023
Q1 | $5.25M | Buy |
54,031
+1,532
| +3% | +$149K | 0.05% | 365 |
|
2022
Q4 | $5.43M | Buy |
52,499
+1,705
| +3% | +$176K | 0.05% | 347 |
|
2022
Q3 | $4.31M | Sell |
50,794
-568
| -1% | -$48.2K | 0.04% | 377 |
|
2022
Q2 | $4.26M | Buy |
51,362
+257
| +0.5% | +$21.3K | 0.04% | 393 |
|
2022
Q1 | $3.94M | Buy |
51,105
+1,184
| +2% | +$91.3K | 0.03% | 485 |
|
2021
Q4 | $4.41M | Sell |
49,921
-1,363
| -3% | -$120K | 0.03% | 461 |
|
2021
Q3 | $3.96M | Sell |
51,284
-85
| -0.2% | -$6.57K | 0.03% | 482 |
|
2021
Q2 | $4.29M | Sell |
51,369
-970
| -2% | -$80.9K | 0.03% | 464 |
|
2021
Q1 | $3.95M | Buy |
52,339
+337
| +0.6% | +$25.4K | 0.03% | 477 |
|
2020
Q4 | $4.56M | Sell |
52,002
-3,024
| -5% | -$265K | 0.04% | 396 |
|
2020
Q3 | $4.19M | Buy |
55,026
+13,135
| +31% | +$999K | 0.04% | 380 |
|
2020
Q2 | $5.17M | Buy |
41,891
+554
| +1% | +$68.3K | 0.07% | 253 |
|
2020
Q1 | $3.49M | Buy |
+41,337
| New | +$3.49M | 0.06% | 360 |
|
2018
Q2 | – | Sell |
-30,034
| Closed | -$2.44M | – | 1531 |
|
2018
Q1 | $2.44M | Sell |
30,034
-3,200
| -10% | -$259K | 0.02% | 886 |
|
2017
Q4 | $2.96M | Buy |
33,234
+2,328
| +8% | +$208K | 0.03% | 816 |
|
2017
Q3 | $2.88M | Buy |
+30,906
| New | +$2.88M | 0.03% | 585 |
|